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binding and presumably sequestering TCF1
and/or modifying its activity.
To determine whether SOX13 is necessary
for gd T cell development, we generated Sox13-
deficient mice. Because of as-yet-uncharacterized
developmental abnormalities in postnatal Sox13−/−
mice (fig. S6), we determined the effect of
Sox13-deficiency during embryonic develop-
ment where there are no overt developmental
defects. No significant differences were ob-
served in the proportions of ab-lineage thymo-
cytes at E18.5 (Fig. 4A). However, there was a
gene dose–dependent decrease in the number
and proportion of gdTCR+ cells in Sox13+/− and
Sox13−/− mice as compared to LMCs (Fig. 4, A
and B), resulting in a significantly increased ratio
of the absolute number of mature ab-lineage
thymocytes relative to gdTCR+ thymocytes
(Fig. 4C). This adverse effect of Sox13 de-
ficiency on gd T cell development was evident
despite the fact that Sox13−/− mice expressed
Sox5, the closest relative of Sox13 (24), whose
expression pattern is identical to that of Sox13
during mouse T cell development (fig. S6). In
addition, Sox13−/− gd and TN thymocytes ex-
hibited significantly enhanced rates of prolifer-
ation (Fig. 4D), a corollary finding to reduced
proliferation of TN thymocytes in Sox13Tg
mice (Fig. 2E). These results indicate that the
developing gd thymocytes are extremely sensi-
tive to the levels of SOX13 and that SOX13 is
necessary for normal gd T cell development.
Sox13 is the first true gd-lineage–specific
TF identified that is necessary for normal gd
T cell development. The heterogeneous ex-
pression of Sox13 in TN2 cells, combined
with the asymmetry in the developmental
potential of the TN2 subset, indicates that
some lineage separation had occurred before
TCR rearrangement. The silencing of Sox13
expression may constitute an initial step in
the elaboration of the ab-lineage molecular
program. Although this conclusion does not
preclude the influence of possibly distinct
gdTCR and preTCR signaling modules in
subsequently reinforcing or modifying the
lineage-fate decision, the ability of SOX13
to antagonize TCF1 suggests that a simple
on/off switch controlling the magnitude of
Wnt/TCF1 signaling may be an early, critical
regulator of the binary T cell–fate decision
process.
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A Systems Approach to Measuring
the Binding Energy Landscapes of
Transcription Factors
Sebastian J. Maerkl1,2 and Stephen R. Quake2*
A major goal of systems biology is to predict the function of biological networks. Although network
topologies have been successfully determined in many cases, the quantitative parameters
governing these networks generally have not. Measuring affinities of molecular interactions in
high-throughput format remains problematic, especially for transient and low-affinity interactions.
We describe a high-throughput microfluidic platform that measures such properties on the basis of
mechanical trapping of molecular interactions. With this platform we characterized DNA binding
energy landscapes for four eukaryotic transcription factors; these landscapes were used to test basic
assumptions about transcription factor binding and to predict their in vivo function.
Systems biology focuses on understandingthe collective properties of biological net-works; these networks in turn describe
interactions between as many as thousands of
unique elements. In recent years, knowledge of
biological networks has grown dramatically,
mainly because of the development and application
of novel genomic (1–3) and proteomic methods
(4–8) as well as bottom-up approaches such as
genetic network engineering (9, 10). But as net-
work topologies are becoming well character-
ized, information about the elements comprising
these networks has remained minimal and in the
realm of low-throughput biology. In order to
model and predict the behavior of these
complex systems, the underlying interactions
between elements will have to be quantitatively
characterized.
Quantifying the affinities of molecular inter-
actions is a considerable technical challenge.
First, any particular biological interaction is
governed by a large number of variables. There-
fore, obtaining equilibrium dissociation con-
stants requires one to perform dozens of assays
as the concentrations of various components are
systematically varied, increasing the number of
measurements needed in an already logistically
challenging problem. A second and more fun-
damental problem is the fact that many molec-
ular interactions are transient and exhibit
nanomolar to micromolar affinities, leading to
rapid loss of bound material or little bound
material in the first place. These factors are
problematic for high-throughput methods such
as yeast two-hybrid (6) and tandem affinity
purification mass spectrometry (4, 5), where
transient interactions are frequently missed.
Protein-protein (11) and protein-DNA binding
microarrays (PBMs) (12–14) are especially
susceptible because of their stringent wash
requirements, causing rapid loss of weakly
bound material. Protein arrays have been
applied to quantify ligand–ErbB receptor inter-
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actions (11), with off rates determined by
surface plasmon resonance to be on the order
of 10−4 s−1 (15). PBMs have been applied in a
semiquantitative manner to transcription factor
(TF) motif analysis for high-affinity interac-
tions, with off rates on the order of 10−3 s−1
(12–14).
We developed a high-throughput microflu-
idic platform (Fig. 1) capable of detecting low-
affinity transient binding events on the basis of
the mechanically induced trapping of molecular
interactions (MITOMI), which eliminates the
off-rate problem facing current array platforms
and allows for absolute affinity measurements.
We used MITOMI to map the binding energy
landscapes of four eukaryotic TFs belonging to
the basic helix-loop-helix (bHLH) family by
collecting over 41,000 individual data points
from more than 17 devices and covering
titrations over 464 target DNA sequences. These
binding energy topographies allowed us to (i)
predict in vivo function for two yeast TFs, (ii)
make a comprehensive test of the base additivity
assumption, and (iii) test the hypothesis that the
basic region alone determines binding specific-
ity of bHLH TFs.
bHLH motifs represent the third largest TF
family in eukaryotes and regulate a wide variety
of cellular functions ranging from cell prolifer-
ation and development to metabolism (16). We
studied isoforms A and B of the human TF
MAX,which together with other bHLHmembers
play a role in cellular proliferation and many
cancers (17).We also studied the yeast TFs Pho4p
and Cbf1p; the former regulates phosphate
metabolism (18, 19), whereas the latter regulates
methionine synthesis as well as chromosome
segregation, serving a structural role in the
kinetochore (20–22). bHLH TFs generally bind
to a consensus sequence of 5′-CANNTG-3′
(where N is any nucleotide) called enhancer
box (E-box) (fig. S1, A and B), which was
later found to be the second most conserved
motif in higher eukaryotes (3). Members of the
bHLH family show mid- to low nanomolar
DNA binding affinities and have off rates
above 10−2 s−1 for their consensus sequences
(23, 24), with orders of magnitude higher off
rates for nonconsensus sequences. This tran-
sience makes the use of conventional micro-
arrays impractical.
The TF binding energy topographies were
measured with highly integrated microfluidic
devices (25, 26) containing 2400 independent
unit cell experiments (Fig. 1, A and B). Each
device is controlled by 7233 valves fabricated
by multilayer soft lithography (MSL) (27) and
programmed with a 2400-spot DNA microarray
(28). The 2400 chambers are arranged into 24
rows addressed via a resistance equalizer (Fig.
1A); this ensures that flow velocities are equal
across all rows, resulting in uniform surface
derivatization and TF deposition. To avoid
time-consuming cloning and protein synthe-
sis and purification steps, we synthesized the
TFs in situ via wheat germ–based in vitro
transcription and translation (ITT). We de-
signed a two-step polymerase chain reaction
(PCR) method that generates linear expression–
ready templates directly from yeast genomic
DNA or cDNA clones (fig. S2). This approach
allowed us to not only rapidly screen new
TFs but also easily create and test structural
chimeras.
We synthesized libraries of Cy5-labeled
target DNA sequences that comprehensively
cover the E-box motif and flanking bases by
permuting up to four bases at a time (fig. S1C
and data set 1). Dilution series for each target
DNA sequence were spotted as microarrays
with column and row pitches of 563 mm and
281 mm, respectively. These arrays were used
to program the microfluidic devices by aligning
Fig. 1. (A) Design drawing of the microfluidic device. Red and blue lines represent control and
flow channels, respectively. The device contains 2400 unit cells controlled by 7233 valves (scale
bar indicates 2 mm). (B) Optical micrograph of three unit cells. Control channels are filled with
colored food dyes for visualization. Each unit cell consists of a DNA chamber aligned to a
microarray spot and a detection area. The valves shown in green control access to the DNA
chambers, whereas the orange valves compartmentalize the unit cells. The button membrane is
shown in blue and represents the area where detection takes place (scale bar, 150 mm). (C)
Schematic outline of the approach. First, a microarray of target DNA sequences is spotted onto an
epoxy slide. The microarray is then aligned and bonded to a microfluidic device. Next, the
necessary surface chemistry is prepared, followed by in situ synthesis of TF and detection of
interactions by MITOMI. (D to F) Schematic of the process of MITOMI. The gray structure at the top
of each panel represents the deflectable button membrane that may be brought into contact with
the glass surface (blue). (D) His5-tagged TFs are localized to the surface, and TF-DNA binding is in a
steady state. (E) The button membrane is brought into contact with the surface, expelling any
solution phase molecules while trapping surface-bound material. (F) Unbound material not
physically protected is washed away, and the remaining molecules are quantified. (G to I)
Fluorescent intensity maps of target DNA concentration. (G) to (I) correspond to the states
schematically shown in (D) to (F) (scale bars, 50 mm).
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each spot to a unit cell. The ability to program
devices with microarrays simplifies the micro-
fluidic infrastructure and increases unit cell
density. The use of microarrays for device pro-
gramming is highly modular because any solu-
ble substance or suspension may be arrayed,
and it provides an elegant and efficient solution
to the world-to-chip interface problem. Ap-
proximately attomoles of DNA and TF are
required for each data point.
Each unit cell is controlled by three mi-
cromechanical valves (27) as well as a
“button” membrane (fig. S3) used for surface
derivatization and MITOMI (Fig. 1, B to I,
and fig. S4). When the button is actuated, it
physically blocks a 60-mm circular area on
the slide, preventing molecules from enter-
ing or leaving that part of the surface. The
contact area can be precisely modulated by
choice of button diameter and closing pres-
sures (fig. S3). During surface derivatization,
a circular area is masked with the button,
while the rest of the surface is passivated
with biotinylated bovine serum albumin.
When the button is released, the previously
protected circular area is specifically func-
tionalized with biotinylated antibody against
His5 (fig. S4, C to G). After surface pat-
terning, the device is loaded with wheat
germ–based ITT mixture containing linear
DNA template coding for the TF to be
synthesized, and each unit cell is isolated by
closing a set of micromechanical valves. The
device is incubated at 30°C for 90 min to
complete TF synthesis, solvation of target
DNA, and equilibration of TF and target
DNA (fig. S4, H and I). After the incubation
period, MITOMI is performed by again
actuating the button membrane and trapping
surface-bound complexes (Fig. 1, D to I, and
fig. S4, J to L). Initial contact of the mem-
brane with the surface occurs medially and
extends radially outward. Radial closure
prevents solvent pockets from forming be-
tween the two interfaces and effectively
creates zero dead volume while preserving
the equilibrium concentrations of the molec-
ular interactions to be detected. The trapped
molecules are subsequently quantified with
a DNA array scanner (fig. S5). Device char-
acterization and control experiments are de-
scribed in the Supporting Online Material
(figs. S6 to S8) (26); we determined the
lower limit of detection to be Kd ≈ 18 mM and
established a global measurement error of
19% (fig. S9).
Our measurements agree with previous re-
ports that the optimal binding sequence for all
four TFs is CACGTG for N−3 to N3 (Fig. 2, A
to D, and figs. S10, A to D, and S11). We
measured consensus binding affinities of 67.0
nM, 73.1 nM, 11.1 nM, and 16.6 nM for MAX
isoform A, MAX isoform B, Pho4p, and
Cbf1p, respectively. The binding affinity of
MAX to a slightly different sequence has been
measured independently and is in agreement
with our result for that sequence (24). Each
binding energy landscape exhibits topographic
fine structures, such as affinity spikes for
sequences with a one-base spacer between
the two half sites (CACGGTG for example)
as well as consensus neighbors CATGTG,
CTCGTG, and CAGGTG. These fine struc-
tures often lie in the low-affinity regime (with
off rates on the order of 2 to 20 s−1) and have
thus far not been observed with other meth-
ods. The binding energy landscapes for both
MAX isoforms are more rugged than the
landscapes of Pho4p and Cbf1p, showing
strong affinities for consensus neighbors,
whereas Pho4p and Cbf1p are singularly
specific for the E-box consensus. These differ-
ences in topography are intriguing, because
crystal structures of truncated versions of MAX
and Pho4p show that both TFs make essen-
tially the same base-specific contacts (29, 30).
Therefore, similar base-specific contacts give
rise to recognition of the same consensus se-
quence but not necessarily to similar overall
binding topographies.
Informatic methods for TF binding motif
discovery often rely on ad hoc hypotheses
such as the additivity assumption, which
Fig. 2. Binding affinities of C-terminally tagged TFs MAX iso A (A), MAX iso B (B), Pho4p (C), and
Cbf1p (D) to all sequence permutations of N−4 to N−1. Sequences N−3 to N−1 are plotted on the
category axis, with the fourth base, N−4, displayed as clusters of four columns per category. (E and
F) Comparisons of predicted changes in the Gibbs free energy (DDG) against measured values for
MAX isoforms A and B are shown, respectively. All predicted values were calculated from PWMs
assuming base independence.
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posits that the energetic or informatic role of
each base in a given motif is independent of
the identity of neighboring bases. Evidence
from small data sets contradicts this assump-
tion (31, 32), but there is an ongoing debate
on the importance of the observed non-
independence (33). Our data on the absolute
binding affinities of the MAX isoforms to all
possible sequence permutations of one E-box
half site plus a flanking base, or 256 se-
quences in total, allowed us to determine the
extent of interdependence between individ-
ual base contacts. First, we generated a
position weight matrix (PWM) for each
isoform, consisting of changes in the Gibbs
free energy for all 16 possible single-base
substitutions. These PWMs were then used
to calculate binding affinities to all 256 se-
quences. Because PWMs contain no informa-
tion on higher-order interactions, the predicted
affinities reflect an assumption of completely
independent base contacts. Comparing our
experimentally determined values with the
predictions showed that only a small subset
of values agreed (Fig. 2, E and F, and fig.
S10, E and F). PWMs fail to predict low-
affinity binding, because almost no sequences
above 2.5 kcal/mol agreed with measured
values (defined as lying within 2s or ±0.4
kcal/mol of the measured value). This is
mostly due to the increasing role of non-
specific interactions, for which failure of the
PWM is not surprising. More importantly,
PWMs also fail for higher affinities, pre-
dicting only 44% of all sequences below 2.5
kcal/mol. The PWMs predicted only 56%,
10%, and 0% of all double, triple, and quad-
ruple substitutions, respectively. The conse-
quences of these results are twofold. First, for
gene discovery applications PWMs will give
low false positives but more potential false
negatives or missed genes. Second, PWMs
are not sufficient for more detailed com-
putational approaches to systems biology that
seek to understand the stochastic dynamics of
TF binding.
To address the question of how Pho4p and
Cbf1p serve distinct biological functions while
recognizing seemingly identical consensus
motifs, we measured the extent to which these
TFs recognize bases flanking the E-box con-
sensus. Current experimental and bioinformatic
methods (1, 7, 34, 35) failed to show definite
differences in sequence recognition between
these two TFs (CACGTGsG and rTCACGTG
for Pho4p and Cbf1p, respectively, where r is
any purine and s is G or C). We measured all
possible permutations of three flanking bases 5′
as well as 3′ of the consensus sequence in order
to determine how far base-specific recognition
extends. The results show that Pho4p specifically
recognizes two flanking bases, extending the
consensus motif to a palindromic decamer of
5′-CCCACGTGGG-3′ (Fig. 3A and fig. S12, A
and B). For Cbf1p, the flanking base recognition
profile differed drastically from Pho4p, preferring
GT as N−5N−4 (Fig. 3B) and the palindrome AC
for N4N5 (fig. S12, C to D). Furthermore T and C
were preferred for N6 (A and G in terms of N−6),
extending Cbf1p sequence recognition from the
initial hexamerous E-box motif to a dodecamer of
5′-[A/G]GTCACGTGAC[T/C]-3′.
On the basis of structural (29, 30) and
biochemical data, it is widely assumed that
the sequence-specific binding of bHLH
TFs is determined entirely by the basic re-
gion. We assessed whether the basic region
itself is sufficient to produce the observed
flanking base sequence specificity by clon-
ing the basic regions of Pho4p and Cbf1p
into the MAX isoform B backbone. The
results show that, despite the existence of a
few intriguing sequence outliers, the basic
region itself is sufficient to transform the
original MAX isoform B recognition pattern
to patterns resembling Pho4p and Cbf1p
(Fig. 3D).
Last, we asked whether the binding ener-
gy landscapes for Pho4p and Cbf1p are
sufficient to predict which genes these TFs
physically bind and therefore likely regulate.
We applied a simple in silico model based on
calculating a probability of occupancy (Pocc)
(36, 37) for each regulatory sequence of 5814
yeast genes and obtained 38 and 24 genes
bound by Pho4p and Cbf1p, respectively.
(Fig. 4, A and B, and data sets 2 and 3). We
then tested whether these gene sets were
significantly enriched for functions related
to Pho4p (phosphate metabolism) and Cbf1p
(methionine metabolism and chromosome
segregation). The Pho4p data set showed
significant enrichment in genes functioning
in ionic homeostasis and phosphate metab-
olism (table S1), with 60% of the genes in
the data set functioning in phosphate metabo-
lism (37%), ionic homeostasis (13%), and
vacuoles (10%) (Fig. 4A). Chromatin immu-
noprecipitation (ChIP)–chip and microarray
experiments determining Pho4p-regulated
genes have only 18% agreement; our data
set includes all of these overlapping genes
and has 40% agreement with at least one of
the other data sets (Fig. 4E). For Cbf1p, the
functional enrichment returned categories
mainly involved in cell cycle and cell growth
(table S1), implying that Cbf1p functions in
chromosome segregation. Of Cbf1p-regulated
genes, 30% are involved in chromosome
structure, and another 25% are involved in
budding (Fig. 4B). Only two genes (8%)
regulate methionine synthesis. We also found
three genes (STE20, GAL2, and DRS2) that
Fig. 3. DDG values of all permutations of the two flanking bases N−5N−4 for Pho4p (A), Cbf1p (B),
and MAX iso B (C). (D) Comparison of the DDG values of the wild-type proteins shown in (A) to (C)
with basic region chimeras in which the basic region of MAX isoform B was replaced by the basic
regions of Pho4p, Cbf1p, and MAX iso B. The average of two experimental values is plotted, with
the difference shown by the error bars.
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had previously been shown to exhibit Cbf1p-
dependent chromatin remodeling (20). We
predict that Cbf1 regulates a much smaller
set of genes than ChIP-chip experiments do,
but there is good agreement because more
than 60% of the genes in our prediction were
also found by ChIP-chip (Fig. 4F). We have
thus shown that augmenting the consensus
binding motifs with the new flanking bases
revealed by the free energy landscapes results
in concrete biological predictions that dif-
ferentiate the function of Pho4 and Cbf1 and
have broad agreement with the biological
literature.
For two yeast TFs we have successfully
predicted biological function by combining
purely in vitro biophysical measurements with
informatic knowledge of the organism's ge-
nome. As the theoretical and experimental
tools of systems biology become more mature,
this situation may become the rule rather than
the exception, and it is worth considering
whether there is any fundamental limit on the
ability to predict biological behavior from in
vitro measurements.
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Fig. 4. In vivo function prediction for Pho4p and Cbf1p. (A and B) Genes with regulatory
sequences determined to be bound by our in silico method. All genes shown here have a Pocc of
above 0.2 and a sensu stricto conservation score of 25% or above. Pie charts show the functional
distribution of the gene sets. (C and D) Venn diagrams comparing our predicted gene sets to gene
sets determined with use of expression microarrays and ChIP-chip.
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